Home LiteratureArticle Details
PMID: 6438672 Published · ppublish English Clinical Trial Controlled Clinical Trial Journal Article Randomized Controlled Trial Research Support, U.S. Gov't, P.H.S.

Relative abuse liability of diazepam and oxazepam: behavioral and subjective dose effects.

Psychopharmacology ·Vol. 84 ·No. 2 ·1984-00-00 ·Pages 147-54

Griffiths RR, McLeod DR, Bigelow GE, Liebson IA, Roache JD

Abstract

The effects of diazepam (10-160 mg) and oxazepam (30-480 mg) were studied in volunteers with histories of drug abuse. Oral doses were administered every third day under double-blind and counterbalanced conditions. Dose-effects with area under the time-action curve data (AUC) showed diazepam to be 2.6-5.7-times more potent than oxazepam on various psychomotor, cognitive, staff-rated, and subjective measures. Comparison of relative potencies showed diazepam to be relatively more potent in producing 'liking' than in producing psychomotor and cognitive effects. Diazepam produced greater peak effects than oxazepam on a number of staff- and subject-rated measures, including liking. Onset of effect was more rapid and time to maximal effect was shorter (1-2 h versus 4-12 h) with diazepam than oxazepam, while time to offset of effect was similar for the two drugs. Diazepam was categorized as producing barbiturate-like subjective effects (38.3%) more frequently than was oxazepam (13.8%), while oxazepam was identified as placebo more often than diazepam. Repeated administration of 160 mg diazepam and 480 mg oxazepam showed that AUC liking was greater for diazepam than oxazepam and that tolerance to psychomotor and cognitive effects occurred with oxazepam but not diazepam. This study suggests that diazepam may have a higher abuse liability than oxazepam.

MeSH Terms
Adult Behavior/drug effects Cognition/drug effects Diazepam/pharmacology Dose-Response Relationship, Drug Drug Tolerance Emotions/drug effects Humans Male Middle Aged Oxazepam/pharmacology Psychomotor Performance/drug effects Sleep/drug effects Substance-Related Disorders/psychology Time Factors
Chemicals
Oxazepam Diazepam
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Griffiths R R
McLeod D R
Bigelow G E
Liebson I A
Roache J D
References (23)
23 references, click to expand
  1. [The addiction potential of benzodiazepines. Application of the results of treatment of alcohol withdrawal syndrome].
    S Afr Med J. 1981 Jan 24;59(4):115-6 PMID: 7455836
  2. Drug preference in humans: double-blind choice comparison of pentobarbital, diazepam and placebo.
    J Pharmacol Exp Ther. 1980 Dec;215(3):649-61 PMID: 7441524
  3. Differential effects of diazepam and pentobarbital on mood and behavior.
    Arch Gen Psychiatry. 1983 Aug;40(8):865-73 PMID: 6870483
  4. Assessment of the abuse liability of buspirone in recreational sedative users.
    J Clin Psychiatry. 1982 Dec;43(12 Pt 2):69-75 PMID: 6130076
  5. Physical dependence on diazepam and lorazepam in the dog.
    J Pharmacol Exp Ther. 1983 Sep;226(3):783-9 PMID: 6136601
  6. Oxazepam in the treatment of anxiety associated with depression: results of treatment in 1600 cases (Studies in depression, VI).
    Curr Med Res Opin. 1981;7(3):156-63 PMID: 7214986
  7. Clinical pharmacokinetics of oxazepam and lorazepam.
    Clin Pharmacokinet. 1981 Mar-Apr;6(2):89-105 PMID: 6111408
  8. Internal stimulus control and subjective effects of drugs.
    NIDA Res Monogr. 1981 Jul;37:116-29 PMID: 6798454
  9. Long v short half-life benzodiazepines in the elderly. Kinetics and clinical effects of diazepam and oxazepam.
    Arch Gen Psychiatry. 1983 Mar;40(3):293-7 PMID: 6830408
  10. Benzodiazepine withdrawal effects.
    Prog Neuropsychopharmacol Biol Psychiatry. 1982;6(4-6):517-22 PMID: 6131488
  11. Effects of different rates of absorption of two benzodiazepins on subjective and objective parameters. Significance for clinical use and risk of abuse.
    Eur J Clin Pharmacol. 1974;7(3):201-11 PMID: 4851741
  12. Progress report of the NIDA Addiction Research Center.
    NIDA Res Monogr. 1982 Apr;41:45-52 PMID: 6811932
  13. Oxazepam: An overview.
    Dis Nerv Syst. 1975 May;36(5 Pt. 2):14-6 PMID: 1140060
  14. Diazepam dose preference in humans.
    Pharmacol Biochem Behav. 1983 Mar;18(3):449-56 PMID: 6835999
  15. Comparison of diazepam and oxazepam: preference, liking and extent of abuse.
    J Pharmacol Exp Ther. 1984 May;229(2):501-8 PMID: 6716272
  16. Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man.
    Clin Pharmacol Ther. 1971 Mar-Apr;12(2):245-58 PMID: 5554941
  17. The clinical activity of oxazepam.
    Acta Psychiatr Scand Suppl. 1978;(274):99-103 PMID: 367060
  18. Diazepam use among methadone maintenance patients: patterns and dosages.
    Drug Alcohol Depend. 1981 Nov;8(3):189-99 PMID: 7327083
  19. Human drug self-administration: double-blind comparison of pentobarbital, diazepam, chlorpromazine and placebo.
    J Pharmacol Exp Ther. 1979 Aug;210(2):301-10 PMID: 458637
  20. Benzodiazepine withdrawal symptoms and propranolol.
    Lancet. 1981 Mar 7;1(8219):520-2 PMID: 6111632
  21. Drug abuse patterns of patients on methadone treatment in New York City.
    Am J Drug Alcohol Abuse. 1981;8(1):17-25 PMID: 7304510
  22. The abuse potential of benzodiazepines with special reference to oxazepam.
    Acta Psychiatr Scand Suppl. 1978;(274):111-6 PMID: 282775
  23. Withdrawal phenomena after long-term administration of benzodiazepines. A review of recent investigations.
    Pharmacopsychiatria. 1983 Jan;16(1):1-8 PMID: 6131447
Article Info
Journal
Psychopharmacology
Abbr.
Psychopharmacology (Berl)
ISSN
0033-3158
Published
1984-00-00
Pages
147-54
Language
English
Region
Germany
NLM ID
7608025
Subset
IM
Grants
NIDA NIH HHS · DA-01022 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com